Strokes caused by an artery tear are landing five times as many Americans in the hospital these days, a new study says.
Teenagers who spend more time on screens tend to get worse sleep, both in terms of sleep quality and duration, researchers reported Wednesday in the journal PLOS Global Public Health.
Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...
Lepodisiran is being developed by biotech giant Eli Lilly & Co. (LLY), a stock that’s in my model portfolio. Here’s the tale of this new drug…how it could help millions of heart-ailment sufferers…and ...
On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...
L'entreprise de télésanté Hims & Hers Health a déclaré lundi qu'elle prévoyait de vendre les médicaments contre le diabète et ...
Explore more
Eli Lilly rolled out positive Phase 2 results for lepodisiran, a therapy targeting lipoprotein(a)—that genetic party crasher ...
“Nearly a quarter of the world’s population has elevated levels of Lp (a), putting them at a significantly higher risk of cardiovascular events such as heart attacks and strokes,” said Steven Nissen, ...
2d
Interesting Engineering on MSNLepodisiran drug shows unprecedented 94% drop in heart disease risk factor: StudyEli Lilly and Company announced encouraging results from a Phase 2 trial of lepodisiran, an investigational therapy aimed at ...
New drug shows promise in lowering Lp(a), a hidden heart risk factor. Especially vital for Black Americans, who often have ...
An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.
A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results